Business
Appointment of European Sales Leader - ProBiotix
Appointment of European Sales Leader - ProBiotix.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 5475V OptiBiotix Health PLC 04 December 2019 \n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n \nAppointment of European Sales Leader for ProBiotix Health Ltd\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces the appointment of Mikkel Hvid-Hansen as European Sales Leader of its wholly-owned subsidiary, ProBiotix Health Ltd (\"ProBiotix\"). \n \nProBiotix was created to develop science based healthy bacteria called probiotics to reduce cardiovascular risk. Independent clinical studies have shown its LPLDL® probiotic can reduce key cardiovascular risk markers such as total cholesterol, LDL (bad) cholesterol, and blood pressure by up to 36.7%, 13.9% and 5.1% respectively. Since launching its CholBiome® products containing LPLDL® in May 2017, ProBiotix has signed over 23 agreements and its products are now commercialised in 23 countries. LPLDL® was designated Generally Recognized As Safe (\"GRAS\") by an independent Expert GRAS Panel in the United States in February 2019, which extends its applications from use as a supplement to use as a functional ingredient in a wide range of food, dairy, and beverage products in the USA. \n \nMikkel is joining ProBiotix from a position as International Sales Manager from Cell Biotech Int. (\"Cell Biotech\"), a Korean probiotic company selling bulk ingredients and finished products internationally. Prior to joining Cell Biotech, Mikkel spent six years as International Sales Manager at Bifodan where he had responsibility for the sales of several probiotic OTC drugs. Previously, Mikkel also worked for Lallemand, the world's third largest probiotic company (1998-2006) and Eraco (1995-1998). Mikkel brings extensive experience of commercialising probiotics products and technologies, a wide network of industry contacts, and a strong track record of rapidly growing sales.\n \nMikkel will be based in Denmark to support existing sales in Europe and extend the market opportunities for LPLDL® within the European probiotic supplement, food, and dairy markets.\n \nSteve Prescott, CEO of ProBiotix Health Ltd., commented: \"Mikkel's experience and track re...